Coagulant Therapeutics

Manufacturing · California, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

2630 Bancroft Way, Berkeley, California,...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Coagulant Therapeutics

Coagulant Therapeutics is focused on developing innovative medicines to address acute bleeding, an unmet medical need associated with conditions such as postpartum hemorrhage and traumatic brain injury. The company leverages over 100 years of collective expertise in the coagulation cascade and biologics, along with a portfolio of over 30 patents, to create optimized hemostatic agents. Their lead product, CT-001, is an engineered Factor VIIa designed to enhance efficacy and safety for patients experiencing acute bleeding. The intended clients include healthcare providers and patients affected by various forms of acute bleeding.Explore more
Coagulant Therapeutics's Social MediaPopular SearchesCoagulant Therapeutics CorpCoagulant TherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Coagulant Therapeutics Org Chart

PhoneEmail
DS
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Coagulant Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Coagulant Therapeutics

Compare insights from companies similar to Coagulant Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Coagulant Therapeutics

<$5M
1-10
Private
-
-
DS
Derek SimChief Scientific Officer
<$5M
1-10
Public
$31.7M
2008
<$5M
1-10
Private
<$5M
2019
JE
Jo EmmettSenior Vice President, Eumentis Therapeutics
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
2012
N/A
<$5M
11-50
Private
-
2017
N/A
<$5M
1-10
Private
-
2016
MP
Michael PalfreymanDrug Development Advisor
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Coagulant Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Coagulant Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Coagulant Therapeutics.

Coagulant Therapeutics Tech Stack

A closer look at the technologies used by Coagulant Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Coagulant Therapeutics

What is Coagulant Therapeutics's official website?
Coagulant Therapeutics's official website is www.coagulanttherapeutics.com
What is Coagulant Therapeutics's Revenue?
Coagulant Therapeutics's revenue is <$5 Million
What is Coagulant Therapeutics's SIC code?
Coagulant Therapeutics's SIC: 28,283
What is Coagulant Therapeutics's NAICS code?
Coagulant Therapeutics's NAICS: 32,325
How many employees does Coagulant Therapeutics have?
Coagulant Therapeutics has 1-10 employees
What industry does Coagulant Therapeutics belong to?
Coagulant Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Coagulant Therapeutics competition?
Coagulant Therapeutics top competitors include: Eumentis Therapeutics, Neuro Biomed, NeurAegis, Versapeutics
What technology does Coagulant Therapeutics use?
Some of the popular technologies that Coagulant Therapeutics uses are: Squarespace Online Stores, Adobe Typekit, Google Font API, Microsoft 365
What does Coagulant Therapeutics do?

Coagulant Therapeutics is focused on developing innovative medicines to address acute bleeding, an unmet medical need associated with conditions such as postpartum hemorrhage and traumatic brain injury. The company leverages over 100 years of collective expertise in the coagulation cascade and biologics, along with a portfolio of over 30 patents, t... o create optimized hemostatic agents. Their lead product, CT-001, is an engineered Factor VIIa designed to enhance efficacy and safety for patients experiencing acute bleeding. The intended clients include healthcare providers and patients affected by various forms of acute bleeding.Read More

What are Coagulant Therapeutics social media links?
Coagulant Therapeutics Linkedin page
Is Coagulant Therapeutics a public company?
Coagulant Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Coagulant Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.